High-resolution CT imaging findings of collagen vascular disease- associated interstitial lung disease

Current Respiratory Medicine Reviews

Volumn 11, Issue 2, 2015, Pages 73-82

  Jokerst, Clint ^a   Azok, Joe ^b   Cummings, Kristopher W ^c   Bhalla, Sanjeev ^c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Acute interstitial pneumonia; Collagen vascular disease; High resolution computed tomography; Interstitial lung disease; Lymphocytic interstitial pneumonia; Nonspecific interstitial pneumonia; Organizing pneumonia; Usual interstitial pneumonia

Indexed keywords

ANKYLOSING SPONDYLITIS; ANTISYNTHETASE SYNDROME; ARTICLE; COLLAGEN DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; INTERSTITIAL LUNG DISEASE; MIXED CONNECTIVE TISSUE DISEASE; POLYMYOSITIS; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 84942092125     PISSN: 1573398X     EISSN: 18756387     Source Type: Journal    
DOI: 10.2174/1573398X11666150619182817     Document Type: Article

References (58)

1. Wells AU. The revised ATS/ERS/JRS/ALAT diagnostic criteria for idiopathic pulmonary fibrosis (IPF)-practical implications. Respir Res 2013; 14(Suppl 1): S2.
2. Kazerooni E. High-Resolution CT of the Lungs. AJR 2001; 177: 501-19.
3. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: Glossary of Terms for Thoracic Imaging. Radiology 2008; 246(3): 697-722.
4. Mittoo S, Gelber AC, Christopher-Stine L, Horton MR, Lechtzin N, Danoff SK. Ascertainment of collagen vascular disease in patients presenting with interstitial lung disease. Respir Med 2009; 103(8): 1152-58.
5. Kim EA, Lee KS, Johkoh T, et al. Interstitial lung diseases associated with collagen vascular diseases: radiologic and histopathologic findings. Radiographics 2002; 22 Spec No: S151-65.
6. Capobianco J, Grimberg A, Thompson BM, et al. Thoracic manifestations of collagen vascular diseases. Radiographics 2012; 32: 33-50.
7. Travis WD, Costabel U, Hansell DM, et al. An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care 2013; 188(6): 733-48.
8. Sato T, Fujita J, Yamadori I, et al. Non-specific interstitial pneumonia; as the first clinical presentation of various collagen vascular disorders. Rheumatol Int 2006; 26: 551-5.
9. Woodhead F, Wells AU, Desai SR. Pulmonary complications of connective tissue diseases. Clin Chest Med 2008; 29(1): 149-64.
10. Walsh SLF, Sverzellati N, Devaraj A, et al. Connective tissue disease related fibrotic lung disease: high resolution computed tomographic and pulmonary function indices as prognostic determinants. Thorax 2014; 69(3): 216-22.
11. Kahler CM, Colleselli D. Pulmonary arterial hypertension (PAH) in connective tissue diseases. Rheumatology 2006; 45: Suppl 3:iii11-3.
12. Hoeper MM. Pulmonary hypertension in collagen vascular disease. Eur Respir J 2002; 19(3): 571-76.
13. Meyer KC, Decker C, Baughman R. Toxicity and monitoring of immunosuppressive therapy used in systemic autoimmune diseases. Clin Chest Med 2010; 31(3): 565-88.
14. Hwang JH, Misumi S, Sahin H, et al. Computed tomographic features of idiopathic fibrosing interstitial pneumonia: comparison with pulmonary fibrosis related to collagen vascular disease. J Comput Assist Tomogr 2009; 33: 410-15.
15. Travis WD, Hunninghake G, King TE, et al. Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med. 2008; 177(12): 1338-47.
16. Silvia CIS, Muller NL. Interstitial lung disease in the setting of collagen vascular disease. Semin Roentgenol 2010; 45(1): 22-8.
17. Kim SJ, Lee KS, Ryu YH, et al. Reversed halo sign on highresolution CT of cryptogenic organizing pneumonia: diagnostic implications. Am J Roentgenol 2003; 180: 1251-54.
18. Cordier JF. Cryptogenic organising pneumonia. ERJ 2006; 28(2): 422-46.
19. American Thoracic Society, European Respiratory Society. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002; 165: 277-304.
20. Desai SR, Nicholson AG, Stewart S, et al. Benign pulmonary lymphocytic infiltration and amyloidosis: computed tomographic and pathologic features in three cases. J Thorac Imaging 1997; 12: 215-20.
21. Silva CI, Muller NL, Fujimoto K, et al. Acute exarcebation of chronic interstitial pneumonia: high-resolution computed tomography and pathologic findings. J Thorac Imaging 2007; 22: 221-9.
22. Gabriel SE. The epidemiology of rheumatoid arthritis. Rheum Dis Clin North Am 2001; 27: 269-81.
23. Bongartz T, Nannini C, Medina-Velasquez YF, et al. Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population-based study. Arthritis Rheum 2010; 62: 1583-91.
24. Lee HK, Kim DS, Yoo B, et al. Histopathologic pattern and clinical features of rheumatoid arthritis-associated interstitial lung disease. Chest 2005; 127: 2019-27.
25. Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175: 705-11.
26. Kim EJ, Collard HR, King Jr TE. Rheumatoid arthritis-associated interstitial lung disease; the relevance of histopathologic and radiographic pattern. Chest 2009; 136(5): 1397-1405.
27. Steen VD, Hochberg MC, Silman AJ, Smolen JS, et al. Epidemiology of systemic sclerosis. Rheumatology. Barcelona, Spain Elsevier Doyma 2003; 1455-62.
28. White B. Interstitial lung disease in scleroderma. Rheum Dis Clin North Am. 2003; 29: 371-90.
29. Bouros D, Wells AU, Nicholson AG, et al. Histopathologic subsets of fibrosing alveolitis in patients with systemic sclerosis and their relationship to outcome. Am J Respir Crit Care Med 2002; 165: 1581-6.
30. Kim DS, Yoo B, Lee JS, et al. The major histopathologic pattern of pulmonary fibrosis in scleroderma is nonspecific interstitial pneumonia. Sarcoidosis Vasc Diffuse Lung Dis 2002; 19: 121-7.
31. Fischer A, Swigris JJ, Groshong SD, et al. Clinically Significant Interstitial Lung Disease in Limited Scleroderma: Histopathology, Clinical Features, and Survival. Chest 2008; 134(3): 601-5.
32. Schwarz MI. The lung in polymyositis. Clin Chest Med 1998; 19(4): 701-12.
33. M Fathi, M Dastmalchi, E Rasmussen, et al. Interstitial lung disease, a common manifestation of newly diagnosed polymyositis and dermatomyositis. Ann Rheum Dis 2004; 63: 297-301.
34. Kang EH, Lee EB, Shin KC, et al. Interstitial lung disease in patients with polymyositis, dermatomyositis and amyopathic dermatomyositis. Rheumatology 2005; 44(10): 1282-6.
35. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositisdermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med 2001; 164(7): 1182-5.
36. Tazelaar HD, Viggiano RW, Pickersgill J, et al. Interstitial lung disease in polymyositis and dermatomyositis. Clinical features and prognosis as correlated with histologic findings. Am Rev Respir Dis 1990; 141(3): 727-33.
37. Arakawa H, Yamada H, Kurihara Y, et al. Nonspecific Interstitial Pneumonia Associated With Polymyositis and Dermatomyositis*:Serial High-Resolution CT Findings and Functional Correlation. Chest 2003; 123(4): 1096-1103.
38. Fischer A, Swigris JJ, du Bois R, et al. Anti-synthetase syndrome in ANA and anti-JO-1 negative patients presenting with idiopathic interstitial pneumonia. Respir Med 2009; 103(11): 1719-24.
39. Solomon J, Swigris JJ, Brown KK. Myositis-related interstitial lung disease and antisynthetase syndrome. J Bras Pneumol 2011; 37(1): 100-9.
40. Sharp GC, Irvin WS, Tan EM, et al. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52(2): 148-59.
41. Prakash UP. Respiratory complications in mixed connective tissue disease. Clin Chest Med 1998; 19(4): 733-46.
42. Bodolay E, Szekanecz Z, Devenyi K, et al. Evaluation of interstitial lung disease in mixed connective tissue disease (MCTD). Rheumatology 2005; 44(5): 656-61.
43. Rahman A, Isenberg DA. Review article: systemic lupus erythematosus. N Engl J Med 2008; 358(9): 929-39.
44. Good JT Jr, King TE, Antony VB, et al. Lupus pleuritis: clinical features and pleural fluid characteristics with special reference to pleural fluid antinuclear antibodies. Chest 1983; 84(6): 714-8.
45. Bernatsky S, Boivin JF, Joseph L, et al. Mortality in systemic lupus erythematosus. Arthritis Rheum 2006; 54(8): 2550-7.
46. Haupt HM, Moore GW, Hutchins GM. The lung in systemic lupus erythematosus. Analysis of the pathologic changes in 120 patients. Am J Med 1981; 71: 791-8.
47. Quadrelli SA, Alvarez C, Arce SC, et al. Pulmonary involvement of systemic lupus erythematosus: analysis of 90 necropsies. Lupus. 2009 ; 18(12): 1053-60.
48. Tansey D, Wells AU, Colby TV, et al. Variations in histological patterns of interstitial pneumonia between connective tissue disorders and their relationship to prognosis. Histopathology 2004; 44(6): 585-96.
49. Tanaka N, Newell JD, Brown KK, et al. Collagen vascular disease related lung disease: high-resolution computed tomography findings based on the pathologic classification. J Comput Assist Tomogr 2004; 28: 351-60.
50. Cain HC, Noble PW, Matthay RA. Pulmonary manifestations of Sjogren's syndrome. Clin Chest Med 1998; 19(4): 687-99.
51. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978; 89(6): 888-92.
52. Lynch DA. Lung disease related to collagen vascular disease. J Thorac Imaging 2009; 24(4): 299-309.
53. Parambil JG, Myers JL, Lindell RM, et al. Interstitial lung disease in primary sjogren syndrome. Chest 2006; 130(5): 1489-95.
54. Boushea DK, Sundstrom WR. The pleuropulmonary manifestations of ankylosing spondylitis. Semin Arthritis Rheum 1989; 18(4): 277-81.
55. Kanathur N, Lee-Chiong T. Pulmonary manifestations of ankylosing spondylitis. Clin Chest Med 2010; 31(3): 547-54.
56. Park JH, Kim DS, Park IN, et al. Prognosis of fibrotic interstitial pneumonia: idiopathic versus collagen vascular disease-related subtypes. Am J Respir Crit Care Med 2007; 175(7): 705-11.
57. Fischer A, West SG, Swigris JJ, et al. Connective tissue diseaseassociated interstitial lung disease: a call for clarification. Chest 2010; 138(2): 251-6.
58. Biederer J, Mirsadraee S, Beer M, et al. MRI of the lung (3/3) -current applications and future perspectives. Insights Imaging 2012; 3(4): 373-86.